Ikena Oncology, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Ikena Oncology, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2020 to 2023.
  • Ikena Oncology, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $1.02M, a 49.1% decline year-over-year.
  • Ikena Oncology, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $6.05M, a 21.8% decline year-over-year.
  • Ikena Oncology, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $7.63M, a 1.42% increase from 2022.
  • Ikena Oncology, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $7.53M, a 45.4% increase from 2021.
  • Ikena Oncology, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $5.18M, a 188% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $7.63M +$107K +1.42% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-12
2022 $7.53M +$2.35M +45.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-12
2021 $5.18M +$3.38M +188% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-14
2020 $1.8M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.